We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Aquestive Petitions FDA to Halt Approval of NDA for Emergency Seizure Spray
Aquestive Petitions FDA to Halt Approval of NDA for Emergency Seizure Spray
Aquestive submitted a citizen petition to the FDA urging the agency to delay approval of Neurelis’ new drug application for its cluster seizure nasal spray Valtoco (diazepam intranasal solution) pending additional clinical studies.